Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
ABT
— Abbott Laboratories
NYSE
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
APR 16, 2026
REVENUE
$11.16B
-2.6%
NET MARGIN
9.6%
-5.9 PTS
EPS
$0.62
-39.2%
FREE CASH FLOW
$916.0M
-65.1%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →